Mikio Oka

The JRS Guidelines for the Management of Community-acquired Pneumonia in Adults:An Update and New Recommendations

Naoyuki Miyashita, Toshiharu Matsushima, Mikio Oka · Internal Medicine · 2006 · 335 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients

Koji Kurose, Yoshihiro Ohue, Hisashi Wada et al. · Clinical Cancer Research · 2015 · 254 citations

Medicine, Immunology, Oncology +16

Transport of 7-Ethyl-10-hydroxycamptothecin (SN-38) by Breast Cancer Resistance Protein ABCG2 in Human Lung Cancer Cells

Katsumi Nakatomi, Megumi Yoshikawa, Mikio Oka et al. · Biochemical and Biophysical Research Communications · 2001 · 188 citations

Medicine, Molecular Biology, Pharmacology +12

Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells

Takeshi Kitazaki, Mikio Oka, Yoichi Nakamura et al. · Lung Cancer · 2005 · 179 citations

Medicine, Oncology, Pharmacology +13

Gefitinib (“Iressa”, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses Breast Cancer Resistance Protein/ABCG2–Mediated Drug Resistance

Yoichi Nakamura, Mikio Oka, Hiroshi Soda et al. · Cancer Research · 2005 · 177 citations · Full text

Medicine, Oncology, Pharmacology +15